Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Clinical trial NCT00104975 · COMPLETED

Trial details

NCT number: NCT00104975
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2005-02-01
Primary completion: 2008-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.